Skip to content

Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting

Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01328743
Enrollment
180
Registered
2011-04-05
Start date
2011-05-31
Completion date
2016-08-31
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hazardous Drinking, HIV

Brief summary

This is a randomized clinical trial to examine the effects of a brief counseling intervention for heavy drinking HIV-infected men who have sex with men compared to HIV care as usual. The study tests the hypothesis that brief counseling will lower drinking in these patients and that reductions in drinking will be associated with better HIV-related outcomes.

Detailed description

This study is a randomized clinical trial in which 224 heavy drinking men who have sex with men (MSM), who receive their HIV primary care at Fenway Health in Boston, are randomly assigned to treatment as usual (TAU) or TAU plus a brief intervention to reduce alcohol use (TAU-BI). TAU-BI will be based in Motivational Interviewing and include personalized feedback tailored to an HIV-infected MSM population. Follow-ups will occur at 3, 6, and 12 months. The first primary aim of the study is to test the hypothesis that TAU-BI, compared to TAU, will result in reduced alcohol consumption over a 12-month follow-up period as indicated by: (1) a lower number of alcoholic drinks consumed per week; (2) a lower number of drinking days within each follow-up period; and (3) a lower number of heavy drinking days within each follow-up period. The second primary aim is to test the hypothesis that greater reductions in alcohol use will be associated with (1) greater adherence to HIV medication regimens; (2) less engagement in high-risk sexual behavior that could result in HIV transmission; (3) lower plasma HIV RNA levels (viral load) (CD4 cell counts will be a secondary outcome in this sub-aim); (4) improved liver function tests; and (5) improved neurocognitive function.

Interventions

3 sessions of individual face-to-face counseling at baseline, 3 and 6 months. Sessions are motivationally focused including discussion of pros and cons of drinking and feedback on health and its relation to heavy drinking

Sponsors

Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* be at least 18 years of age * drink heavily at least once per month on average (≥5 drinks) or drink more than 14 drinks per week * have a confirmed diagnosis of HIV/AIDS * be a male who has had sex (oral or anal) with a male partner in the past 3 months.

Exclusion criteria

* current intravenous drug use * currently psychotic, suicidal, or manic * are currently being treated or have been treated in the past 3 months for an HIV-related opportunistic infection * currently receiving treatment for an alcohol or drug problem

Design outcomes

Primary

MeasureTime frameDescription
Number of Alcoholic Drinks Consumed12 monthsNumber of standard alcoholic drinks consumed per week in the past month
Number of Heavy Drinking Days12 monthsNumber of heavy drinking days (drinking 5 or more drinks in a day) in the past month

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment as Usual
Treatment as usual in an HIV primary care setting. Participants receive assessment of alcohol use but not counseling or advice regarding drinking.
91
Brief Alcohol Intervention
Participants receive 3 face-to-face sessions of counseling on alcohol use and 2 follow-up phone calls Brief alcohol intervention: 3 sessions of individual face-to-face counseling at baseline, 3 and 6 months. Sessions are motivationally focused including discussion of pros and cons of drinking and feedback on health and its relation to heavy drinking
89
Total180

Baseline characteristics

CharacteristicTreatment as UsualTotalBrief Alcohol Intervention
Age, Continuous43.2 years
STANDARD_DEVIATION 10.5
42.1 years
STANDARD_DEVIATION 10.4
41.0 years
STANDARD_DEVIATION 10.3
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants31 Participants16 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
76 Participants149 Participants73 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
21 Participants35 Participants14 Participants
Race (NIH/OMB)
More than one race
5 Participants9 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
64 Participants134 Participants70 Participants
Region of Enrollment
United States
91 Participants180 Participants89 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
91 Participants180 Participants89 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 910 / 89
other
Total, other adverse events
0 / 910 / 89
serious
Total, serious adverse events
0 / 910 / 89

Outcome results

Primary

Number of Alcoholic Drinks Consumed

Number of standard alcoholic drinks consumed per week in the past month

Time frame: 12 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Alcoholic Drinks Consumed11.6 drinks per week
Brief Alcohol InterventionNumber of Alcoholic Drinks Consumed7.2 drinks per week
p-value: 0.04t-test, 2 sided
Primary

Number of Alcoholic Drinks Consumed

Number of standard alcoholic drinks consumed per week in the past month

Time frame: 3 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Alcoholic Drinks Consumed14.4 drinks per week
Brief Alcohol InterventionNumber of Alcoholic Drinks Consumed11.9 drinks per week
p-value: 0.25t-test, 2 sided
Primary

Number of Alcoholic Drinks Consumed

Number of standard alcoholic drinks consumed per week in the past month

Time frame: 6 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Alcoholic Drinks Consumed14.5 drinks per week
Brief Alcohol InterventionNumber of Alcoholic Drinks Consumed8.0 drinks per week
p-value: <0.001t-test, 2 sided
Primary

Number of Heavy Drinking Days

Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month

Time frame: 12 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Heavy Drinking Days3 Days
Brief Alcohol InterventionNumber of Heavy Drinking Days1 Days
p-value: <0.01Wilcoxon (Mann-Whitney)
Primary

Number of Heavy Drinking Days

Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month

Time frame: 6 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Heavy Drinking Days4 Days
Brief Alcohol InterventionNumber of Heavy Drinking Days2 Days
p-value: <0.01Wilcoxon (Mann-Whitney)
Primary

Number of Heavy Drinking Days

Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month

Time frame: 3 months

ArmMeasureValue (MEDIAN)
Treatment as UsualNumber of Heavy Drinking Days4 Days
Brief Alcohol InterventionNumber of Heavy Drinking Days3 Days
p-value: 0.48Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026